High white matter lesion load is associated with hippocampal atrophy in mild cognitive impairment

C Eckerström1, E Olsson, N Klasson

  • 1Institute of Neuroscience and Physiology, University of Gothenburg, Gothenburg, Sweden. carl.eckrtston@neuro.gu.se

Abstract

Insights

White matter lesions (WML) are linked to hippocampal atrophy in mild cognitive impairment (MCI) patients. Significant atrophy occurred only when WML volume reached a critical threshold, suggesting a potential diagnostic marker.

Area of Science:

  • Neurology
  • Neuroimaging
  • Cognitive Science

Background:

  • Mild cognitive impairment (MCI) is a complex condition potentially preceding Alzheimer's disease (AD) and subcortical vascular dementia (SVD).
  • Emerging evidence links white matter lesions (WML) to hippocampal atrophy, a key feature in dementia.
  • Understanding this relationship is crucial for early diagnosis and intervention in MCI.

Purpose of the Study:

  • To quantify hippocampal and WML volumes in individuals with MCI.
  • To investigate the association between WML and hippocampal atrophy in the MCI population.

Main Methods:

  • Utilized data from the Gothenburg MCI study, a longitudinal cohort with 166 participants (92 stable MCI, 30 converting MCI, 44 controls).
  • Measured WML volumes manually using MRIcron.
  • Performed automated segmentation of hippocampal and total white matter volumes via FreeSurfer.

Main Results:

  • Patients converting from MCI to dementia exhibited reduced hippocampal volume.
  • Converting MCI patients showed significantly higher WML volumes compared to controls.
  • Hippocampal volume correlated with WML volume (ρ = 0.57; p < 0.01) specifically within the quartile of patients with the highest WML burden.

Conclusions:

  • Hippocampal atrophy is a common finding in both AD and SVD.
  • The association between hippocampal volume and WML volume appears to be dependent on a WML volume threshold.
  • These findings suggest that WML accumulation may need to exceed a certain level before causing noticeable hippocampal atrophy in MCI.

Related Concept Videos

Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Role of Hippocampus in Memory01:19

Role of Hippocampus in Memory

The hippocampus, a critical brain structure, plays an essential role in memory processing, particularly in the formation and retrieval of memory. This small, seahorse-shaped region is located within the medial temporal lobe, with one hippocampus in each brain hemisphere. Experimental studies involving lesions in the hippocampi of rats have demonstrated significant impairments in tasks such as object recognition and maze navigation, indicating the hippocampus involvement in both recognition and...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.